Exparel 133 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DX25F6AFR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $22,608
Award facts
- Contract value 100% obligated
- $22,608.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain organization, awarded a delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of EXPAREL (133 mg/10 mL vial) with a ceiling value of $22,608.30. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and will be performed in Park Ridge, Illinois. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group—a woman-owned small business pharmaceutical wholesaler—to compete directly in the federal marketplace.
DMS Pharmaceutical Group Inc. is fulfilling this delivery order under its larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. This master contract enables the agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide, encompassing branded and generic prescription drugs, biologics, and medical consumables. As an established federal pharmaceutical supplier registered in SAM.gov since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in delivering specialized pharmaceutical products to Department of Defense healthcare sites across multiple product categories.
Quick answers
Who was awarded contract SPE2DX25F6AFR?
SPE2DX25F6AFR was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 9, 2025.
How much is contract SPE2DX25F6AFR worth?
The government has obligated $22,608 on SPE2DX25F6AFR.
Is contract SPE2DX25F6AFR an order under another contract?
Yes. SPE2DX25F6AFR is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AFR competed?
The extent of competition for SPE2DX25F6AFR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award